APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cyclosporine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Cyclosporine Industry Growth and Trends Forecast to 2032

20 December 2025106 pages

Choose your research edition.

Industry ResearchCyclosporine Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Cyclosporine Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Cyclosporine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cyclosporine Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Cyclosporine Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Cyclosporine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Cyclosporine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Cyclosporine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cyclosporine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cyclosporine include Alcon, Allergan, Herantis Pharma, Mimetogen Pharmaceuticals, Mitotech, Otsuka Pharmaceutical, Regenerx Biopharmaceuticals, Santen Pharmaceutical and United Biotech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Cyclosporine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Cyclosporine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cyclosporine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cyclosporine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Cyclosporine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Cyclosporine Market by Company

Alcon

Allergan

Herantis Pharma

Mimetogen Pharmaceuticals

Mitotech

Otsuka Pharmaceutical

Regenerx Biopharmaceuticals

Santen Pharmaceutical

United Biotech

Takeda

Cyclosporine Segment by Type

Pills

Oral

Cyclosporine Segment by Application

Hospital

Clinic

Others

Cyclosporine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cyclosporine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cyclosporine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cyclosporine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cyclosporine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Cyclosporine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Pills Table 2. Major Company of Oral Table 3. Global Cyclosporine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Cyclosporine Sales by Type (2021-2026) & (K Units) Table 5. Global Cyclosporine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Cyclosporine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Cyclosporine Sales Market Share in Value by Type (2021-2026) Table 8. Global Cyclosporine Price by Type (2021-2026) & (US$/Unit) Table 9. Global Cyclosporine Sales by Type (2027-2032) & (K Units) Table 10. Global Cyclosporine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Cyclosporine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Cyclosporine Sales Market Share in Value by Type (2027-2032) Table 13. Global Cyclosporine Price by Type (2027-2032) & (US$/Unit) Table 14. North America Cyclosporine Sales by Type (2021-2026) & (K Units) Table 15. North America Cyclosporine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Cyclosporine Sales by Type (2021-2026) & (K Units) Table 17. Europe Cyclosporine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Cyclosporine Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Cyclosporine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Cyclosporine Sales by Type (2021-2026) & (K Units) Table 21. Latin America Cyclosporine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Cyclosporine Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Cyclosporine Sales by Type (2021-2026) & (US$ Million) Table 24. Cyclosporine Industry Trends Table 25. Cyclosporine Industry Drivers Table 26. Cyclosporine Industry Opportunities and Challenges Table 27. Cyclosporine Industry Restraints Table 28. Global Cyclosporine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Cyclosporine Revenue Market Share by Company (2021-2026) Table 30. Global Cyclosporine Sales by Company (2021-2026) & (K Units) Table 31. Global Cyclosporine Sales Share by Company (2021-2026) Table 32. Global Cyclosporine Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Cyclosporine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Cyclosporine Major Company Production Sites and Headquarters Table 35. Global Cyclosporine Company, Product Type & Application Table 36. Global Cyclosporine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Cyclosporine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Cyclosporine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Cyclosporine Sales by Region (2021-2026) & (K Units) Table 41. Global Cyclosporine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Cyclosporine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Cyclosporine Sales Market Share in Value by Region (2021-2026) Table 44. Global Cyclosporine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Cyclosporine Sales by Region (2027-2032) & (K Units) Table 46. Global Cyclosporine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Cyclosporine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Cyclosporine Sales Market Share in Value by Region (2027-2032) Table 49. Global Cyclosporine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Cyclosporine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Cyclosporine Sales by Application (2021-2026) & (K Units) Table 52. Global Cyclosporine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Cyclosporine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Cyclosporine Sales Market Share in Value by Application (2021-2026) Table 55. Global Cyclosporine Price by Application (2021-2026) & (US$/Unit) Table 56. Global Cyclosporine Sales by Application (2027-2032) & (K Units) Table 57. Global Cyclosporine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Cyclosporine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Cyclosporine Sales Market Share in Value by Application (2027-2032) Table 60. Global Cyclosporine Price by Application (2027-2032) & (US$/Unit) Table 61. North America Cyclosporine Sales by Application (2021-2026) & (K Units) Table 62. North America Cyclosporine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Cyclosporine Sales by Application (2021-2026) & (K Units) Table 64. Europe Cyclosporine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Cyclosporine Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Cyclosporine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Cyclosporine Sales by Application (2021-2026) & (K Units) Table 68. Latin America Cyclosporine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Cyclosporine Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Cyclosporine Sales by Application (2021-2026) & (US$ Million) Table 71. Alcon Company Information Table 72. Alcon Business Overview Table 73. Alcon Cyclosporine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Alcon Cyclosporine Product Portfolio Table 75. Alcon Recent Development Table 76. Allergan Company Information Table 77. Allergan Business Overview Table 78. Allergan Cyclosporine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Allergan Cyclosporine Product Portfolio Table 80. Allergan Recent Development Table 81. Herantis Pharma Company Information Table 82. Herantis Pharma Business Overview Table 83. Herantis Pharma Cyclosporine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Herantis Pharma Cyclosporine Product Portfolio Table 85. Herantis Pharma Recent Development Table 86. Mimetogen Pharmaceuticals Company Information Table 87. Mimetogen Pharmaceuticals Business Overview Table 88. Mimetogen Pharmaceuticals Cyclosporine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Mimetogen Pharmaceuticals Cyclosporine Product Portfolio Table 90. Mimetogen Pharmaceuticals Recent Development Table 91. Mitotech Company Information Table 92. Mitotech Business Overview Table 93. Mitotech Cyclosporine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Mitotech Cyclosporine Product Portfolio Table 95. Mitotech Recent Development Table 96. Otsuka Pharmaceutical Company Information Table 97. Otsuka Pharmaceutical Business Overview Table 98. Otsuka Pharmaceutical Cyclosporine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Otsuka Pharmaceutical Cyclosporine Product Portfolio Table 100. Otsuka Pharmaceutical Recent Development Table 101. Regenerx Biopharmaceuticals Company Information Table 102. Regenerx Biopharmaceuticals Business Overview Table 103. Regenerx Biopharmaceuticals Cyclosporine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Regenerx Biopharmaceuticals Cyclosporine Product Portfolio Table 105. Regenerx Biopharmaceuticals Recent Development Table 106. Santen Pharmaceutical Company Information Table 107. Santen Pharmaceutical Business Overview Table 108. Santen Pharmaceutical Cyclosporine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Santen Pharmaceutical Cyclosporine Product Portfolio Table 110. Santen Pharmaceutical Recent Development Table 111. United Biotech Company Information Table 112. United Biotech Business Overview Table 113. United Biotech Cyclosporine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. United Biotech Cyclosporine Product Portfolio Table 115. United Biotech Recent Development Table 116. Takeda Company Information Table 117. Takeda Business Overview Table 118. Takeda Cyclosporine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Takeda Cyclosporine Product Portfolio Table 120. Takeda Recent Development Table 121. North America Cyclosporine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. North America Cyclosporine Sales by Country (2021-2026) & (K Units) Table 123. North America Cyclosporine Sales Market Share by Country (2021-2026) Table 124. North America Cyclosporine Sales Forecast by Country (2027-2032) & (K Units) Table 125. North America Cyclosporine Sales Market Share Forecast by Country (2027-2032) Table 126. North America Cyclosporine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. North America Cyclosporine Market Size by Country (2021-2026) & (US$ Million) Table 128. North America Cyclosporine Market Share by Country (2021-2026) Table 129. North America Cyclosporine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. North America Cyclosporine Market Share Forecast by Country (2027-2032) Table 131. Europe Cyclosporine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Europe Cyclosporine Sales by Country (2021-2026) & (K Units) Table 133. Europe Cyclosporine Sales Market Share by Country (2021-2026) Table 134. Europe Cyclosporine Sales Forecast by Country (2027-2032) & (K Units) Table 135. Europe Cyclosporine Sales Market Share Forecast by Country (2027-2032) Table 136. Europe Cyclosporine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Europe Cyclosporine Market Size by Country (2021-2026) & (US$ Million) Table 138. Europe Cyclosporine Market Share by Country (2021-2026) Table 139. Europe Cyclosporine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Europe Cyclosporine Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Cyclosporine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Cyclosporine Sales by Country (2021-2026) & (K Units) Table 143. Asia-Pacific Cyclosporine Sales Market Share by Country (2021-2026) Table 144. Asia-Pacific Cyclosporine Sales Forecast by Country (2027-2032) & (K Units) Table 145. Asia-Pacific Cyclosporine Sales Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Cyclosporine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Cyclosporine Market Size by Country (2021-2026) & (US$ Million) Table 148. Asia-Pacific Cyclosporine Market Share by Country (2021-2026) Table 149. Asia-Pacific Cyclosporine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Asia-Pacific Cyclosporine Market Share Forecast by Country (2027-2032) Table 151. Latin America Cyclosporine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. Latin America Cyclosporine Sales by Country (2021-2026) & (K Units) Table 153. Latin America Cyclosporine Sales Market Share by Country (2021-2026) Table 154. Latin America Cyclosporine Sales Forecast by Country (2027-2032) & (K Units) Table 155. Latin America Cyclosporine Sales Market Share Forecast by Country (2027-2032) Table 156. Latin America Cyclosporine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Latin America Cyclosporine Market Size by Country (2021-2026) & (US$ Million) Table 158. Latin America Cyclosporine Market Share by Country (2021-2026) Table 159. Latin America Cyclosporine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Latin America Cyclosporine Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Cyclosporine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Cyclosporine Sales by Country (2021-2026) & (K Units) Table 163. Middle East and Africa Cyclosporine Sales Market Share by Country (2021-2026) Table 164. Middle East and Africa Cyclosporine Sales Forecast by Country (2027-2032) & (K Units) Table 165. Middle East and Africa Cyclosporine Sales Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Cyclosporine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Cyclosporine Market Size by Country (2021-2026) & (US$ Million) Table 168. Middle East and Africa Cyclosporine Market Share by Country (2021-2026) Table 169. Middle East and Africa Cyclosporine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Middle East and Africa Cyclosporine Market Share Forecast by Country (2027-2032) Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. Cyclosporine Distributors List Table 174. Cyclosporine Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. Cyclosporine Image Figure 2. Global Cyclosporine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cyclosporine Market Size (2021-2032) & (US$ Million) Figure 4. Global Cyclosporine Sales (2021-2032) & (K Units) Figure 5. Pills Image Figure 6. Global Pills Sales YoY Growth (2021-2032) & (K Units) Figure 7. Oral Image Figure 8. Global Oral Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Cyclosporine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Cyclosporine Market Share by Type 2025 VS 2032 Figure 11. North America Cyclosporine Sales Market Share in Volume by Type in 2025 Figure 12. North America Cyclosporine Sales Market Share in Value by Type in 2025 Figure 13. Europe Cyclosporine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Cyclosporine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Cyclosporine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Cyclosporine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Cyclosporine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Cyclosporine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Cyclosporine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Cyclosporine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Cyclosporine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Cyclosporine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Cyclosporine Market Share by Application 2025 VS 2032 Figure 31. North America Cyclosporine Sales Market Share in Volume by Application in 2025 Figure 32. North America Cyclosporine Sales Market Share in Value by Application in 2025 Figure 33. Europe Cyclosporine Sales Market Share in Volume by Application in 2025 Figure 34. Europe Cyclosporine Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Cyclosporine Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Cyclosporine Sales Market Share in Value by Application in 2025 Figure 37. Latin America Cyclosporine Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Cyclosporine Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Cyclosporine Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Cyclosporine Sales Market Share in Value by Application in 2025 Figure 41. North America Cyclosporine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Cyclosporine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Cyclosporine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Cyclosporine Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Cyclosporine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Cyclosporine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Cyclosporine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Cyclosporine Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Cyclosporine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Cyclosporine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Cyclosporine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Cyclosporine Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Cyclosporine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Cyclosporine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Cyclosporine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Cyclosporine Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Cyclosporine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Cyclosporine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Cyclosporine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Cyclosporine Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Cyclosporine Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Cyclosporine Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Pills
  • Oral
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Alcon
  • Allergan
  • Herantis Pharma
  • Mimetogen Pharmaceuticals
  • Mitotech
  • Otsuka Pharmaceutical
  • Regenerx Biopharmaceuticals
  • Santen Pharmaceutical
  • United Biotech
  • Takeda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Cyclosporine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Cyclosporine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Cyclosporine Market by Type
  6. 1.3.1 Pills
  7. 1.3.2 Oral
  8. 1.4 Global Cyclosporine Market Size by Type
  9. 1.4.1 Global Cyclosporine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Cyclosporine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Cyclosporine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Cyclosporine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Cyclosporine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Cyclosporine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Cyclosporine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Cyclosporine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Cyclosporine Industry Trends
  2. 2.2 Cyclosporine Industry Drivers
  3. 2.3 Cyclosporine Industry Opportunities and Challenges
  4. 2.4 Cyclosporine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Cyclosporine Revenue (2021-2026)
  2. 3.2 Global Top Players by Cyclosporine Sales (2021-2026)
  3. 3.3 Global Top Players by Cyclosporine Price (2021-2026)
  4. 3.4 Global Cyclosporine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cyclosporine Major Company Production Sites & Headquarters
  6. 3.6 Global Cyclosporine Company, Product Type & Application
  7. 3.7 Global Cyclosporine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cyclosporine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cyclosporine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cyclosporine Tier 1, Tier 2, and Tier 3
4 Cyclosporine Regional Status and Outlook
  1. 4.1 Global Cyclosporine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Cyclosporine Historic Market Size by Region
  3. 4.2.1 Global Cyclosporine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Cyclosporine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Cyclosporine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Cyclosporine Forecasted Market Size by Region
  7. 4.3.1 Global Cyclosporine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Cyclosporine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Cyclosporine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Cyclosporine by Application
  1. 5.1 Cyclosporine Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Cyclosporine Market Size by Application
  6. 5.2.1 Global Cyclosporine Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Cyclosporine Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Cyclosporine Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Cyclosporine Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Cyclosporine Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Cyclosporine Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Cyclosporine Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Cyclosporine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Alcon
  2. 6.1.1 Alcon Company Information
  3. 6.1.2 Alcon Business Overview
  4. 6.1.3 Alcon Cyclosporine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Alcon Cyclosporine Product Portfolio
  6. 6.1.5 Alcon Recent Developments
  7. 6.2 Allergan
  8. 6.2.1 Allergan Company Information
  9. 6.2.2 Allergan Business Overview
  10. 6.2.3 Allergan Cyclosporine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Allergan Cyclosporine Product Portfolio
  12. 6.2.5 Allergan Recent Developments
  13. 6.3 Herantis Pharma
  14. 6.3.1 Herantis Pharma Company Information
  15. 6.3.2 Herantis Pharma Business Overview
  16. 6.3.3 Herantis Pharma Cyclosporine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Herantis Pharma Cyclosporine Product Portfolio
  18. 6.3.5 Herantis Pharma Recent Developments
  19. 6.4 Mimetogen Pharmaceuticals
  20. 6.4.1 Mimetogen Pharmaceuticals Company Information
  21. 6.4.2 Mimetogen Pharmaceuticals Business Overview
  22. 6.4.3 Mimetogen Pharmaceuticals Cyclosporine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Mimetogen Pharmaceuticals Cyclosporine Product Portfolio
  24. 6.4.5 Mimetogen Pharmaceuticals Recent Developments
  25. 6.5 Mitotech
  26. 6.5.1 Mitotech Company Information
  27. 6.5.2 Mitotech Business Overview
  28. 6.5.3 Mitotech Cyclosporine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Mitotech Cyclosporine Product Portfolio
  30. 6.5.5 Mitotech Recent Developments
  31. 6.6 Otsuka Pharmaceutical
  32. 6.6.1 Otsuka Pharmaceutical Company Information
  33. 6.6.2 Otsuka Pharmaceutical Business Overview
  34. 6.6.3 Otsuka Pharmaceutical Cyclosporine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Otsuka Pharmaceutical Cyclosporine Product Portfolio
  36. 6.6.5 Otsuka Pharmaceutical Recent Developments
  37. 6.7 Regenerx Biopharmaceuticals
  38. 6.7.1 Regenerx Biopharmaceuticals Company Information
  39. 6.7.2 Regenerx Biopharmaceuticals Business Overview
  40. 6.7.3 Regenerx Biopharmaceuticals Cyclosporine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Regenerx Biopharmaceuticals Cyclosporine Product Portfolio
  42. 6.7.5 Regenerx Biopharmaceuticals Recent Developments
  43. 6.8 Santen Pharmaceutical
  44. 6.8.1 Santen Pharmaceutical Company Information
  45. 6.8.2 Santen Pharmaceutical Business Overview
  46. 6.8.3 Santen Pharmaceutical Cyclosporine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Santen Pharmaceutical Cyclosporine Product Portfolio
  48. 6.8.5 Santen Pharmaceutical Recent Developments
  49. 6.9 United Biotech
  50. 6.9.1 United Biotech Company Information
  51. 6.9.2 United Biotech Business Overview
  52. 6.9.3 United Biotech Cyclosporine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 United Biotech Cyclosporine Product Portfolio
  54. 6.9.5 United Biotech Recent Developments
  55. 6.10 Takeda
  56. 6.10.1 Takeda Company Information
  57. 6.10.2 Takeda Business Overview
  58. 6.10.3 Takeda Cyclosporine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Takeda Cyclosporine Product Portfolio
  60. 6.10.5 Takeda Recent Developments
7 North America by Country
  1. 7.1 North America Cyclosporine Sales by Country
  2. 7.1.1 North America Cyclosporine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Cyclosporine Sales by Country (2021-2026)
  4. 7.1.3 North America Cyclosporine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Cyclosporine Market Size by Country
  6. 7.2.1 North America Cyclosporine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Cyclosporine Market Size by Country (2021-2026)
  8. 7.2.3 North America Cyclosporine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Cyclosporine Sales by Country
  2. 8.1.1 Europe Cyclosporine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Cyclosporine Sales by Country (2021-2026)
  4. 8.1.3 Europe Cyclosporine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Cyclosporine Market Size by Country
  6. 8.2.1 Europe Cyclosporine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Cyclosporine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Cyclosporine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Cyclosporine Sales by Country
  2. 9.1.1 Asia-Pacific Cyclosporine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Cyclosporine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Cyclosporine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Cyclosporine Market Size by Country
  6. 9.2.1 Asia-Pacific Cyclosporine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Cyclosporine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Cyclosporine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Cyclosporine Sales by Country
  2. 10.1.1 South America Cyclosporine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Cyclosporine Sales by Country (2021-2026)
  4. 10.1.3 South America Cyclosporine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Cyclosporine Market Size by Country
  6. 10.2.1 South America Cyclosporine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Cyclosporine Market Size by Country (2021-2026)
  8. 10.2.3 South America Cyclosporine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Cyclosporine Sales by Country
  2. 11.1.1 Middle East and Africa Cyclosporine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Cyclosporine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Cyclosporine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Cyclosporine Market Size by Country
  6. 11.2.1 Middle East and Africa Cyclosporine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Cyclosporine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Cyclosporine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Cyclosporine Value Chain Analysis
  2. 12.1.1 Cyclosporine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Cyclosporine Production Mode & Process
  7. 12.2 Cyclosporine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Cyclosporine Distributors
  10. 12.2.3 Cyclosporine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst